跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Buclirich - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Buclirich
Approved
STANDARD
Buclirich
Lloyd Laboratores, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b811437d8e08c401
Company
Lloyd Laboratores, Inc.
Type
Standard
Approval Details
Approval Id
b811437d8e08c401
Drug Approval Philippines Name
Buclirich
Product Name
Buclirich
Registration Number
DRP-6827-05
Brand Name
Buclirich
Generic Name
Multivitamins + Buclizine Hydrochloride + Iron
Dosage Form
Capsule
Dosage Strength
see reverse CPR
Manufacturer
Lloyd Laboratores, Inc.
Trader
D.B. Manix International, Inc.
Distributor
Eadriex Pharmaceuticals Phils,Inc.
Issuance Date
25 July 2023
Expiry Date
15 July 2028
Pharmacologic Category
Vitamins and Minerals
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b811437d8e08c401
Type
Standard
Back to Philippines FDA Approvals